Cholangiocarcinoma

You have access
Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial–Mesenchymal Transition Process
SUREERAT PADTHAISONG, MALINEE THANEE, ANCHALEE TECHASEN, NISANA NAMWAT, PUANGRAT YONGVANIT, AEKKAPHOD LIWATTHAKUN, KHITTISAK HANKLA, SAKKARN SANGKHAMANON and WATCHARIN LOILOME

Anticancer Research July 2017, 37 (7) 3591-3597;
You have access
Chemoembolization with Drug-eluting Microspheres Loaded with Doxorubicin for the Treatment of Cholangiocarcinoma
CAMILLO ALIBERTI, RICCARDO CARANDINA, DONATELLA SARTI, ENRICO PIZZIRANI, GAETANO RAMONDO, LUCA MULAZZANI, GIAN MARIA MATTIOLI and GIAMMARIA FIORENTINI

Anticancer Research April 2017, 37 (4) 1859-1863;
You have access
Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB
CHARUPONG SAENGBOONMEE, WUNCHANA SEUBWAI, UBON CHA'ON, KANLAYANEE SAWANYAWISUTH, SOPIT WONGKHAM and CHAISIRI WONGKHAM

Anticancer Research January 2017, 37 (1) 115-123;
You have access
Novel Synthetic Mono-triazole Glycosides Induce G₀/G₁ Cell-cycle Arrest and Apoptosis in Cholangiocarcinoma Cells
SUMALEE OBCHOEI, RUNGNAPHA SAEENG, CHAISIRI WONGKHAM and SOPIT WONGKHAM

Anticancer Research November 2016, 36 (11) 5965-5973;
You have access
Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma
XURUI DAI, SUYANEE THONGCHOT, HASAYA DOKDUANG, WATCHARIN LOILOME, NARONG KHUNTIKEO, ATTAPOL TITAPUN, PITI UNGARREEVITTAYA, PUANGRAT YONGVANIT, ANCHALEE TECHASEN and NISANA NAMWAT

Anticancer Research November 2016, 36 (11) 5981-5988;
You have access
Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells
NAYOUNG KIM, SANG HYUB LEE, JUN HYUK SON, JAE MIN LEE, MIN-JUNG KANG, BO HYE KIM, JUNG-SU LEE, JI KON RYU and YONG-TAE KIM

Anticancer Research November 2016, 36 (11) 6109-6116;
You have access
A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma
CHUN-NAN YEH, SHANG-YU WANG, YEN-YANG CHEN, MING-HUANG CHEN, KUN-CHUN CHIANG, CHI-TUNG CHENG, CHUN-YI TSAI, CHIH-CHI WANG, TA-SEN YEH and TSE-CHING CHEN

Anticancer Research August 2016, 36 (8) 4249-4258;
You have access
Initial Results of Hypofractionated Carbon Ion Radiotherapy for Cholangiocarcinoma
TAKANORI ABE, KEI SHIBUYA, YOSHINORI KOYAMA, MASAHIKO OKAMOTO, HIROKI KIYOHARA, HIROYUKI KATOH, HIROHUMI SHIMADA, HIROYUKI KUWANO, TATSUYA OHNO and TAKASHI NAKANO

Anticancer Research June 2016, 36 (6) 2955-2960;
You have access
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study
ROSA AUTORINO, GIAN CARLO MATTIUCCI, FRANCESCO ARDITO, MARIO BALDUCCI, FRANCESCO DEODATO, GABRIELLA MACCHIA, GIOVANNA MANTINI, VINCENZO PERRI, ANDREA TRINGALI, MARIA ANTONIETTA GAMBACORTA, LUCA TAGLIAFERRI, FELICE GIULIANTE, ALESSIO GIUSEPPE MORGANTI and VINCENZO VALENTINI

Anticancer Research February 2016, 36 (2) 737-740;
You have access
Targeted Therapy for Resistant Cholangiocarcinoma with Bevacizumab or Cetuximab Added to Failed Cytotoxic Drug Cores
HOWARD W. BRUCKNER, AZRIEL HIRSCHFELD and MYRON SCHWARTZ

Anticancer Research January 2016, 36 (1) 399-402;

Main menu

User menu

Search

Cholangiocarcinoma

Pages